How many employees does Catalyst Biosciences have this year?
Catalyst Biosciences has 21 undefined employees this year.
Catalyst Biosciences Employees 2024
Catalyst Biosciences Employees
21
Ticker
CBIO
ISIN
US14888D2080
WKN
A2DLUK
In 2024, Catalyst Biosciences employed 21 people, a 0% change from the 21 number of employees in the previous year.
Catalyst Biosciences Aktienanalyse
What does Catalyst Biosciences do?
Catalyst Biosciences Inc. is a biotechnology company specializing in the development of innovative therapies for rare diseases and severe bleeding disorders. They collaborate with doctors, academics, and patient organizations to bring new treatment options to the market. Their business model is based on the development of proteins that influence the blood clotting process to prevent or reduce bleeding. They use a proprietary technology called Protease Engineering Platform (PEP) to make customized proteins. Catalyst Biosciences Inc. focuses on therapies for rare diseases such as hemophilia A and B, hemorrhagic diathesis, and other rare diseases like factor XIII deficiency or thrombasthenia. They offer a range of products, including CB 2679d, CB 813d, and CB 2679f for the treatment of hemophilia B. Catalyst Biosciences Inc. has achieved milestones and is considered one of the most promising companies in the industry. With its innovative technology and comprehensive portfolio, it has the potential for further success. Catalyst Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining Catalyst Biosciences's Employee Base
Catalyst Biosciences's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Catalyst Biosciences's operational capacity and future potential.
Year-to-Year Comparison
Assessing Catalyst Biosciences's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
Catalyst Biosciences's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in Catalyst Biosciences’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about Catalyst Biosciences stock
How many employees did Catalyst Biosciences have compared to the previous year?
Compared to the previous year, Catalyst Biosciences had 0% more employees.
What impact did the number of employees have on the company Catalyst Biosciences?
The number of employees has a direct impact on the efficiency and productivity of Catalyst Biosciences. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of Catalyst Biosciences?
The number of employees can also have an impact on investors of Catalyst Biosciences, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of Catalyst Biosciences affect the company?
An increase in equity of Catalyst Biosciences can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in Catalyst Biosciences's equity affect the company?
A reduction in equity of Catalyst Biosciences can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of Catalyst Biosciences?
Some factors that can influence the equity of Catalyst Biosciences include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of Catalyst Biosciences so important for investors?
The equity of Catalyst Biosciences is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at Catalyst Biosciences influence the company?
The number of employees at Catalyst Biosciences can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at Catalyst Biosciences evolved in recent years?
In recent years, the number of employees at Catalyst Biosciences has changed by 0.
How many employees does Catalyst Biosciences currently have?
Catalyst Biosciences currently has 21 undefined employees.
Why is the number of employees important for investors of Catalyst Biosciences?
The number of employees is important for investors of Catalyst Biosciences as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can Catalyst Biosciences take to change the number of employees?
To change the number of employees, Catalyst Biosciences can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does Catalyst Biosciences pay?
Over the past 12 months, Catalyst Biosciences paid a dividend of 1.43 USD . This corresponds to a dividend yield of about 8.01 %. For the coming 12 months, Catalyst Biosciences is expected to pay a dividend of 0.24 USD.
What is the dividend yield of Catalyst Biosciences?
The current dividend yield of Catalyst Biosciences is 8.01 %.
When does Catalyst Biosciences pay dividends?
Catalyst Biosciences pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Catalyst Biosciences?
Catalyst Biosciences paid dividends every year for the past 0 years.
What is the dividend of Catalyst Biosciences?
For the upcoming 12 months, dividends amounting to 0.24 USD are expected. This corresponds to a dividend yield of 1.34 %.
In which sector is Catalyst Biosciences located?
Catalyst Biosciences is assigned to the 'Health' sector.
Wann musste ich die Aktien von Catalyst Biosciences kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Catalyst Biosciences from 1/12/2023 amounting to 0.24 USD, you needed to have the stock in your portfolio before the ex-date on 1/13/2023.
When did Catalyst Biosciences pay the last dividend?
The last dividend was paid out on 1/12/2023.
What was the dividend of Catalyst Biosciences in the year 2023?
In the year 2023, Catalyst Biosciences distributed 1.43 USD as dividends.
In which currency does Catalyst Biosciences pay out the dividend?
The dividends of Catalyst Biosciences are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Catalyst Biosciences
Our stock analysis for Catalyst Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Catalyst Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Catalyst Biosciences Revenue
- Catalyst Biosciences Net Income
- Catalyst Biosciences P/E
- Catalyst Biosciences P/S
- Catalyst Biosciences EBIT
- Catalyst Biosciences Dividend
- Catalyst Biosciences Stocks
- Catalyst Biosciences Market capitalization
- Catalyst Biosciences Debt
- Catalyst Biosciences Liabilities
- Catalyst Biosciences Equity
- Catalyst Biosciences AAQS
- Catalyst Biosciences Employees
- Catalyst Biosciences ROE
- Catalyst Biosciences ROA
- Catalyst Biosciences ROCE
